Top Markets
Coin of the day
Beijing Leadman Biochemistry Co.,Ltd. Beijing Leadman Biochemistry Co.,Ltd.

Beijing Leadman Biochemistry Co.,Ltd.

300289
Rank in Stocks #13635
Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's... Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.
Share Price
$0.87093245
Market Cap
$473.80M
Change (1 day)
-1.48%
Change (1 year)
-24.54%
Country
CN
Trade Beijing Leadman Biochemistry Co.,Ltd. (300289)

Category

P/S ratio for Beijing Leadman Biochemistry Co.,Ltd. (300289)
P/S ratio as of 2026 TTM: 0
According to Beijing Leadman Biochemistry Co.,Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Beijing Leadman Biochemistry Co.,Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.13 -
US
5.03 -
US
2.78 -
IE
3.67 -
US
8.10 -
US